UBS Starts Tabula Rasa Healthcare (TRHC) at Buy
- Japan's Nikkei posts biggest point gain for fiscal year
- Citi downgrades tech stocks as its flagship indicator signals 'euphoria' levels
- UBS sees 5 warnings signals on semiconductor chip stocks
- 2 reasons why Tesla stock fell on Thursday
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- AMC Entertainment (AMC) Enters $250M ATM Agreement
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Home Depot (HD) to Acquire SRS Distribution for $18.25B EV
Baird Starts Tabula Rasa Healthcare (TRHC) at Outperform
October 24, 2016 7:43 AM EDTBaird initiated coverage on Tabula Rasa Healthcare (NASDAQ: TRHC) with an Outperform rating and a price target of $17.00.
For an analyst ratings summary and ratings history on Tabula Rasa Healthcare click here. For more ratings news on Tabula Rasa Healthcare click here.
Shares of Tabula Rasa Healthcare closed at $14.23 yesterday.
... MoreUPDATE: Stifel Starts Tabula Rasa Healthcare (TRHC) at Buy
October 24, 2016 7:43 AM EDT(Updated - October 24, 2016 9:34 AM EDT)
Stifel initiated coverage on Tabula Rasa Healthcare (NASDAQ: TRHC) with a Buy rating and a price target of $17.
Analyst Thomas A. Carrol said, "TRHC may offer investors outsized returns in the coming two years as revenue... More
Wells Fargo Starts Tabula Rasa Healthcare (TRHC) at Outperform
October 24, 2016 7:43 AM EDTWells Fargo initiated coverage on Tabula Rasa Healthcare (NASDAQ: TRHC) with an Outperform rating.
For an analyst ratings summary and ratings history on Tabula Rasa Healthcare click here. For more ratings news on Tabula Rasa Healthcare click here.
Shares of Tabula Rasa Healthcare closed at $14.23 yesterday.
... MorePiper Jaffray Starts Tabula Rasa Healthcare (TRHC) at Overweight
October 24, 2016 7:42 AM EDTPiper Jaffray initiated coverage on Tabula Rasa Healthcare (NASDAQ: TRHC) with an Overweight rating and a price target of $18.00.
For an analyst ratings summary and ratings history on Tabula Rasa Healthcare click... More